Magnetar Financial’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,419,805
Closed -$14.3M 627
2022
Q4
$14.3M Hold
1,419,805
0.24% 111
2022
Q3
$14M Buy
1,419,805
+1,091,979
+333% +$10.7M 0.19% 142
2022
Q2
$3.21M Buy
327,826
+317,517
+3,080% +$3.11M 0.03% 472
2022
Q1
$101K Hold
10,309
﹤0.01% 1133
2021
Q4
$101K Hold
10,309
﹤0.01% 1225
2021
Q3
$100K Buy
+10,309
New +$99.8K ﹤0.01% 1199

Other funds holding COCH

Magnetar Financial's COCH Position: Q1 2023 in Review

Magnetar Financial sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 1,419,805 shares — an estimated $14.3M sold.

Magnetar Financial first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $14.3M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Magnetar Financial reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Magnetar Financial sold 1,419,805 Envoy Medical shares in Q1 2023, an estimated $14.3M.
  • Magnetar Financial first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
  • Magnetar Financial's Envoy Medical position peaked at $14.3M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.